PE dives into therapeutic drug manufacturing: 5 deals

Archimed, Ardian and Webster Equity Partners are among the PE firms targeting assets in the therapeutic drug manufacturing sector.

ByJohn R Fischer

17 October 2025•3 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Featured Europe North America US Healthcare Top Stories